All the news Showing 10 of 349 articles from: Injecting drug useGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Ukraine: viral hepatitis and harm reduction services for refugees Keith Alcorn / 10 May 2022 The European Association for the Study of the Liver (EASL), the World Health Organization (WHO) and the European Centre for Disease Prevention and Control have issued a joint statement on viral hepatitis care ... UK report urges re-think on hepatitis C reinfection Keith Alcorn / 11 April 2022 Progress towards the elimination of hepatitis C is being undermined by a lack of attention to the harm reduction needs of people cured of hepatitis C in the United Kingdom, as ... Prioritise harm reduction services to prevent hepatitis C re-infection, Scottish study finds Keith Alcorn / 24 January 2022 Limiting re-infection with hepatitis C in people who use drugs is most likely to be achieved by intensifying provision of sterile injecting equipment for people using needle and syringe programmes and increasing ... One in five new cases of hepatitis C in people who inject drugs due to unstable housing, modelling shows Keith Alcorn / 11 January 2022 Unstable housing may be responsible for up to one in five new infections with HIV or hepatitis C among people who inject drugs in the United Kingdom and the United States, a ... Short stay in prison increases the risk of hepatitis C for people who use drugs Keith Alcorn / 03 September 2021 People who use drugs were over 50% more likely to acquire hepatitis C between 2004 and 2019 if they spent even a brief period in prison, a prospective study carried out in ... Swiss opioid substitution therapy programme reports strong progress towards hepatitis C elimination Keith Alcorn / 14 April 2021 Direct-acting antiviral treatment cured almost everyone treated for hepatitis C in a large cohort of people receiving opioid substitution therapy, Swiss researchers report in the Swiss Medical Weekly. The study also observed a ... Homelessness ‘substantially’ increases BBV risk for people who inject drugs Drink & Drugs News / 07 April 2021 Eliminating hepatitis C through the power of community pharmacies Company Chemists' Association / 07 April 2021 12 good practices that should be part of the hepatitis C standard of care Keith Alcorn / 25 March 2021 Hepatitis C programmes and health services should review whether they are using best practices in diagnosis, treatment and care of people with hepatitis C, and update service models to improve hepatitis C elimination ... Bacterial infection of the heart on the rise among people with hepatitis C in United States Keith Alcorn / 23 June 2020 Diagnoses of infective endocarditis, a life-threatening bacterial infection of the heart valves, have become more common over the past ten years among people with hepatitis C and people with opioid use disorder ... ← First12345...35Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Transfusion and medical procedures Injecting drug use Mother to child Sexual transmission Non-medical blood transfer HBV vaccination Epidemiology Screening and testing policy Health services, policy and advocacy Social issues Conference news Email bulletin archive